4.6 Article

The impact of anti-tumor approaches on the outcomes of cancer patients with COVID-19: a meta-analysis based on 52 cohorts incorporating 9231 participants

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Hematology

SARS-CoV-2 infection among patients with haematological disorders: Severity and one-month outcome in 66 Danish patients in a nationwide cohort study

Andreas Glenthoj et al.

Summary: This prospective study in Danish haematology patients with SARS-CoV-2 infection indicated that older age, severe comorbidities, and critical infection severity were associated with higher mortality rates.

EUROPEAN JOURNAL OF HAEMATOLOGY (2021)

Article Oncology

An online tool for predicting the prognosis of cancer patients with SARS-CoV-2 infection: a multi-center study

Congkuan Song et al.

Summary: A retrospective study on 223 cancer patients with SARS-CoV-2 in Hubei, China revealed significant differences in clinical characteristics between survivors and non-survivors, with patients with hematological malignancies having a worse prognosis. The study also demonstrated the usefulness of an individualized nomogram and online tool in predicting prognosis and developing treatment strategies for cancer patients during the COVID-19 epidemic.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)

Article Oncology

Characteristics and outcomes of coronavirus disease 2019 (COVID-19) patients with cancer: a single-center retrospective observational study in Tokyo, Japan

Shohei Nakamura et al.

Summary: This study found that mortality in cancer patients with COVID-19 was significantly associated with factors including lymphocyte count, albumin, lactate dehydrogenase, serum ferritin, and C-reactive protein. Patients who recently received cytotoxic chemotherapy or chemotherapy that leads to lymphocyte reduction had a poor prognosis and longer periods of viral shedding.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Oncology

Hospitalization rates and 30-day all-cause mortality among head and neck cancer patients and survivors with COVID-19

Glenn J. Hanna et al.

Summary: The study revealed a high 30-day all-cause mortality rate among head and neck cancer patients with COVID-19, with most patients not on active cancer therapy.

ORAL ONCOLOGY (2021)

Article Oncology

Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition

Aljosja Rogiers et al.

Summary: This study investigated the impact of immune checkpoint inhibition (ICI) on the severity of COVID-19 in cancer patients infected with SARS-CoV-2. The findings showed that mortality related to COVID-19 in ICI-treated cancer patients did not appear to be higher than previously reported rates for cancer patients, although inpatient mortality was high compared to hospitalized cancer patients overall. Factors associated with adverse outcomes in ICI-treated patients with COVID-19 were also identified.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Letter Dermatology

COVID-19 in melanoma patients: Results of the Spanish Melanoma Group Registry, GRAVID study

Maria Gonzalez-Cao et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)

Article Oncology

Multivariate mortality analyses in COVID-19: Comparing patients with cancer and patients without cancer in Louisiana

Michael J. Lunski et al.

Summary: This study indicates that patients with cancer have higher mortality rates after contracting COVID-19, especially older age, history of chronic kidney disease, obesity, and other factors increase the risk of death. Risk stratification of these patients will be important in managing future outbreaks.

CANCER (2021)

Article Oncology

Clinical characteristics and risk factors for in-hospital mortality of lung cancer patients with COVID-19: A multicenter, retrospective, cohort study

Lei Nie et al.

Summary: This study revealed that lung cancer patients with COVID-19 exhibit atypical early symptoms and imaging features. Prolonged prothrombin time and elevated high sensitivity cardiac troponin I are independent risk factors associated with in-hospital mortality of lung cancer patients with COVID-19.

THORACIC CANCER (2021)

Review Medicine, Research & Experimental

COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges

Anup S. Pathania et al.

Summary: COVID-19, caused by the novel coronavirus, has a significant impact globally, with cancer patients being particularly vulnerable. During the pandemic, a multidisciplinary approach is crucial for managing the care of cancer patients.

THERANOSTICS (2021)

Editorial Material Oncology

Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China

Wenhua Liang et al.

LANCET ONCOLOGY (2020)

Editorial Material Biochemistry & Molecular Biology

COVID-19 infection: the perspectives on immune responses

Yufang Shi et al.

CELL DEATH AND DIFFERENTIATION (2020)

Article Biochemistry & Molecular Biology

A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2

Cassandra L. Atzrodt et al.

FEBS JOURNAL (2020)

Article Virology

Clinical characteristics and outcomes of cancer patients with COVID-19

Fan Yang et al.

JOURNAL OF MEDICAL VIROLOGY (2020)

Article Medicine, General & Internal

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

Nicole M. Kuderer et al.

LANCET (2020)

Article Medicine, General & Internal

COVID-19 and Italy: what next?

Andrea Remuzzi et al.

LANCET (2020)

Article Oncology

COVID-19 in patients with lung cancer

J. Luo et al.

ANNALS OF ONCOLOGY (2020)

Article Hematology

Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies

Jose Maria Sanchez-Pina et al.

EUROPEAN JOURNAL OF HAEMATOLOGY (2020)

Editorial Material Oncology

Disparities in Cancer Outcomes Due to COVID-19-A Tale of 2 Cities

Onyinye D. Balogun et al.

JAMA ONCOLOGY (2020)

Article Biochemistry & Molecular Biology

Determinants of COVID-19 disease severity in patients with cancer

Elizabeth V. Robilotti et al.

NATURE MEDICINE (2020)

Article Oncology

Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer

David J. Pinato et al.

CANCER DISCOVERY (2020)

Article Oncology

Chemotherapy and COVID-19 Outcomes in Patients With Cancer

Justin Jee et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)

Article Multidisciplinary Sciences

Cancer inpatients with COVID-19: A report from the Brazilian National Cancer Institute

Andreia C. de Melo et al.

PLOS ONE (2020)

Article Oncology

Impact of the COVID-19 Pandemic on Cancer Care: A Global Collaborative Study

Abdul Rahman Jazieh et al.

JCO GLOBAL ONCOLOGY (2020)

Article Genetics & Heredity

Chemotherapy-induced genotoxic damage to bone marrow cells: long-term implications

Jennifer E. May et al.

MUTAGENESIS (2018)

Article Oncology

Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy

Suzanne L. Topalian et al.

CANCER CELL (2015)

Article Medicine, General & Internal

The systemic immune response to trauma: an overview of pathophysiology and treatment

Janet M. Lord et al.

LANCET (2014)

Article Nursing

Significant Impairment in Immune Recovery After Cancer Treatment

Duck-Hee Kang et al.

NURSING RESEARCH (2009)

Review Oncology

Lung infections after cancer chemotherapy

Sandro Vento et al.

LANCET ONCOLOGY (2008)